Providers Support FDA Quest For Public Drug Manufacturing Quality Ratings

Agency agrees with those who prescribe and buy drugs on need to incentivize quality. Except providers want it yesterday.

Businessman pressing smiley face emoticon on virtual touch screen. Customer service evaluation concept.
ratings would improve drug quality, but when? • Source: Shutterstock

Public drug quality ratings would benefit patients and consumers, US Food and Drug Administration officials and health care providers agreed at a recent Duke Margolis Center for Health Policy workshop in Washington, DC, that was marked by sharp differences between the agency and providers over the current state of quality.

Agency officials focused on how they are assuring the public of acceptable brand and generic drug quality, while providers raised...

More from Manufacturing

More from Compliance